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The retroviral restriction factor tripartite motif– containing
5 (Trim5) acts during the early postentry stages of the retro-
viral life cycle to block infection by a broad range of retroviruses,
disrupting reverse transcription and integration. The mecha-
nism of this restriction is poorly understood, but it has recently
been suggested to involve recruitment of components of the
autophagy machinery, including members of the mammalian
autophagy-related 8 (ATG8) family involved in targeting pro-
teins to the autophagosome. To better understand the molec-
ular details of this interaction, here we utilized analytical
ultracentrifugation to characterize the binding of six ATG8
isoforms and determined the crystal structure of the Trim5
Bbox coiled-coil region in complex with one member of the
mammalian ATG8 proteins, autophagy-related protein LC3
B (LC3B). We found that Trim5 binds all mammalian
ATG8s and that, unlike the typical LC3-interacting region
(LIR) that binds to mammalian ATG8s through a -strand
motif comprising approximately six residues, LC3B binds to
Trim5 via the -helical coiled-coil region. The orientation
of the structure demonstrated that LC3B could be accommo-
dated within a Trim5 assembly that can bind the retroviral
capsid. However, mutation of the binding interface does not
affect retroviral restriction. Comparison of the typical linear
-strand LIR with our atypical helical LIR reveals a conserva-
tion of the presentation of residues that are required for the
interaction with LC3B. This observation expands the range of
LC3B-binding proteins to include helical binding motifs and
demonstrates a link between Trim5 and components of the
autophagosome.
The ATG8-like proteins are essential for expansion of the
phogophore membrane and mediate targeting and assembly
of protein complexes to the autophagosome (1). The six
mammalian ATG8 (mATG8)3 isoforms (LC3A, LC3B, LC3C,
GABARAP, GABARAPL1, and GABARAPL2) are orthologues
of the Saccharomyces cerevisiae ATG8 protein and share a con-
served sequence and structure. Structurally, the mATG8s con-
sist of a -grasp fold that is shared with ubiquitin and ubiquitin-
like proteins (2). In addition, mATG8s have two further helices
at the N terminus that complete the fold. A conjugation path-
way similar to the ubiquitin conjugation system results in the
proteins being C-terminally lipidated with phosphatidyletha-
nolamine, providing an anchor to the autophagosomal mem-
brane. As key components of selective autophagy, they can act
to target specific proteins to the autophagosome together with
proteins and organelles targeted for destruction within the
autophagosome.
The mATG8s bind target proteins through a conserved LC3-
interacting region (LIR) (3). The mATG8s, and their interac-
tion with the LIR motif, has been well-characterized by struc-
tural biology (2, 4 – 6). The typical LIR motif is formed by a large
hydrophobic residue and a small hydrophobic residue sepa-
rated by two intervening amino acids that are not arginine,
glycine, proline, or lysine. It is often accompanied by an acidic
residue at the N-terminal end of the motif giving the following
prosite (7) motif annotation [DEST][WFY]-{RGKP}{RGKP}-
[ILV]. Upon binding, the LIR motif forms an extended -strand
that extends the central -sheet packing parallel to strand 2.
Similarly a GABARAP-interacting motif has recently been
described where a small hydrophobic residue is located imme-
diately following the large hydrophobic residue (8). The large
and small hydrophobic residues of the LIR are accommodated
within two hydrophobic pockets located on the surface of the
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ATG8 protein (2) The first pocket, often termed the W pocket,
accommodates the large hydrophobic residue, and the second
pocket, often termed the L pocket, accommodates the small
hydrophobic residue.
Recently, several studies have described a link between mem-
bers of the TRIM (tripartite motif– containing) protein family
and autophagy (9 –13). Members of the TRIM protein family
are characterized by a conserved N-terminal domain architec-
ture consisting of a RING domain, which confers E3 ubiquitin
ligase activity; one or two Bbox domains; and a coiled-coil
region (14). The C-terminal domain of TRIM proteins is varied
with a PRY/SPRY domain being the most common (15). The
coiled-coil region assembles as an elongated anti-parallel dimer
placing the RING and Bbox domains from each monomer at
opposite ends of the coiled-coil, separating them by 160 Å
(16 –18). Family members act in many cellular pathways, with
approximately one-third implicated in innate immunity (19 –
22). One of the most studied family members is the antiretro-
viral postentry restriction factor Trim5.
Trim5 acts during early stages of the retroviral life cycle to
prevent retroviral infection, disrupting reverse transcription
and integration of the virus. The restriction of a particular virus
requires recognition of the intact lattice of capsid protein that
forms the inner shell of the retrovirus (23, 24). Recognition of
the incoming virus is mediated by the C-terminal domain PRY/
SPRY domain. A set of variable loops in the PRY/SPRY domain
dictates the subset of viruses that the Trim5 of different spe-
cies is able to restrict (25).
Trim5 blocks infection during at least two stages of the
retroviral life cycle. The first block, prior to reverse transcrip-
tion, is contingent on the ubiquitin-proteasome system and
results in premature disassembly of the capsid core and release
of viral proteins and RNA (26). Inhibition of the proteasome or
disruption of the Trim5 RING domain prevents Trim5 from
blocking reverse transcription but does not rescue infection,
indicating the presence of a second block to infection (27, 28).
In 2014 Mandell et al. (9) used a siRNA screen to show that a
large number of TRIM proteins alter the number of LC3B
puncta in cells, suggesting a role in regulating autophagy. In
these experiments Trim5 was proposed to act as a selective
autophagy receptor, targeting a restricted virus to the autopha-
gosome for degradation. Furthermore, using co-immunopre-
cipitation they demonstrated potential interactions with com-
ponents of the autophagic machinery including ULK1, beclin1,
sequestosome1/p62, and members of the mATG8 family.
To investigate the interaction between Trim5 and compo-
nents of the autophagy machinery, we have undertaken in vitro
experiments, using purified proteins, to examine the interac-
tion between members of the mammalian ATG8 family and the
coiled-coil region of Trim5. We have demonstrated a direct
interaction and determined the strength and stoichiometry of
this interaction. Furthermore, we have crystallized the complex
between Trim5 and LC3B. Our structure demonstrates that a
cryptic LIR is located in the Trim5 coiled-coil -helix and that
an LIR need not be present as a -strand or disordered region of
the protein. Although retroviral infection assays demonstrate
that the interaction is not required for restriction of HIV-1, this
structure demonstrates an expanded range of binding sites for
LC3B and members of the mammalian ATG8 proteins and pro-
vides a structural link between Trim5 and components of the
autophagosome.
Results
Trim5 binds directly to the six mammalian ATG8 isoforms
The interaction between mATG8 family members and
Trim5 was identified by co-immunoprecipitation studies (9).
Further peptide array experiments then mapped binding to
regions of the Trim5 coiled-coil domain. This suggests an
atypical interaction, because ATG8 proteins usually bind an
LIR motif found in a -strand or unstructured loop. To address
this discrepancy, we sought to reproduce the interaction with
purified components.
To do this, we utilized a construct of Trim5 from Rhesus
macaque encompassing the Bbox coiled-coil regions with an
E120K/R121D mutation (RhT5 88 –296 EK/RD) that blocks the
higher-order assembly of the protein (16, 29), and LC3B
expressed in Escherichia coli. Our initial small-scale pulldown
experiments failed to recapitulate the interaction. Therefore,
we employed sedimentation velocity analytical ultracentrifuga-
tion (SV–AUC) to examine the interaction between the
Trim5 coiled-coil and LC3B where the two components were
closer to equilibrium conditions. Analysis was undertaken
Figure 1. SV–AUC analysis shows that purified Trim5 binds to six iso-
forms of mATG8s. A, c(s) analysis of SV–AUC of 20 M LC3B, RhT5 88 –296
EK/RD, or an equimolar mixture. B, c(s) analysis of 20 M of RhT5 88 –296
EK/RD and equimolar concentration of the six mATG8 isoforms. C, c(s) analysis
of 20 M RhT5 88 –296 EK/RD and increasing concentrations (0 –320 M) of
either LC3B or GABARAPL1. D, peak centroid position derived from integra-
tion of the c(s) function from C versus LC3B or GABARAPL1 concentration. A
one-site binding model has been used to determine the equilibrium dissoci-
ation constant (dashed lines).
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using the continuous distribution of sedimentation coefficients
function, c(s), for each component alone and an equimolar mix-
ture of RhT5 88 –296 EK/RD and LC3B (Fig. 1A). The c(s) dis-
tribution for RhT5 88 –296 EK/RD and LC3B showed symmet-
ric peaks with sedimentation coefficients of 2.74 S (S20,w 2.86 S)
and 1.56 S (S20,W 1.7 S), respectively, consistent with RhT5
88 –296 EK/RD being a dimer and LC3B being a monomer.
Analysis of the mixture showed a slow-moving peak at 1.56 S
corresponding to free LC3B and a fast-moving peak at 2.90 S.
This peak is at a greater S value than that seen for RhT5 88 –296
EK/RD alone and represents the unresolved co-sedimentation
of both the RhT5 88 –296 EK/RD and the 88–296 EK/RD
LC3B complex components. Because no peak was observed for
free RhT5 88 –296 EK/RD, this suggests that the interaction is
under fast exchange in solution relative to the time of sedimen-
tation (30).
To determine whether the interaction with Trim5 is com-
mon to all mATG8s, we undertook further sedimentation
velocity experiments employing RhT5 88 –296 EK/RD and
LC3A, LC3C, GABARAP, GABARAPL1, and GABARAPL2
and analyzed the effect on the position of the fast-moving peak.
In each case the addition of a mATG8 resulted in an increase in
the apparent sedimentation coefficient in the integrated c(s)
of the RhT5 88 –296 EK/RD peak. Based upon the magnitude of
the change in the peak position, that likely corresponds to the
strength of the interaction, the rank order of affinity was
GABARAPL1 followed by GABARAP, LC3B, GABARAPL2,
and LC3C, with LC3A being the weakest (Fig. 1B).
To measure the affinity of the interaction, two representative
mATG8 proteins, LC3B and GABARAPL1, were chosen and
titrated (0 –320 M) against a 20 M RhT5 88 –296 EK/RD
and analyzed binding by SV–AUC. In both the LC3B and
GABARAPL1 titrations, a concentration-dependent shift was
observed for the fast-moving species with the S value of the
peak increasing as the concentration of either protein was
increased. To determine the affinity of the interaction, the S
value of the faster moving peak in the c(s) distribution was inte-
grated and plotted against the ATG8 protein concentration.
The curve was then fit to a single site-binding model. The equi-
librium dissociation constant (KD) determined in this manner
was 103  9 and 78  6 M for LC3B and GABARAPL1, respec-
tively (Fig. 1, C and D).
LC3B binds directly to the Trim5 coiled-coil via helical LIR
motif
To identify the site of interaction of mATG8s within the
Trim5 coiled-coil, we undertook crystallization experiments
employing RhT5 88 –296 EK/RD and all the mATG8s. Crystals
of a complex between RhT5 88 –296 EK/RD and LC3B were
obtained and harvested for X-ray diffraction analysis. The crys-
tals diffracted anisotropically to a resolution of 4.11–2.74 Å and
belong to the space group P22121. The structure was deter-
mined by molecular replacement using the structure of the
Bbox coiled-coil region of Trim5 (PDB code 4TN3) and LC3B
(PDB code 3WAO) as search models. The structure was refined
to a final R/Rfree of 25.9%/27.4%, respectively. Two copies of
RhT5 88 –296 EK/RD and two copies of LC3B are present in the
asymmetric unit (full data collection and model refinement sta-
tistics are presented in Table 1). The final model comprises
residues 95–288 of RhT5 and residues 88 –296 and 4 –117 of
LC3B.
The two RhT5 88 –296 EK/RD monomers are arranged as an
elongated antiparallel dimer as seen previously (Fig. 2A). Com-
parison of the refined model with our previous structure of the
Trim5 Bbox and coiled-coil reveals a high degree of structural
similarity with an root-mean-square deviation of 1.1 Å across
equivalent C atoms (Fig. S1). There is no evidence of flexibility
in the coiled-coil between this model and the previously deter-
mined structure as was observed when comparing other struc-
tures of Trim protein coiled-coils (17, 18).
The two LC3B molecules adopt the typical ubiquitin-like fold
and are highly similar to previously determined structures
(root-mean-square deviation 0.9 Å to PDB code 2LUE) (Fig.
S1). Within the crystal they are positioned toward the center
and on either side of the Trim5 coiled-coil. Each LC3B mono-
mer makes essentially identical interactions with a single RhT5
88 –296 EK/RD monomer with no interactions between the
two LC3B molecules.
Table 1
Data collection and refinement statistics
The statistics for the highest resolution shell are shown in parentheses.
RhT5 88 –296 E120K/R121D:
LC3B 2–119
Data collection statistics
Diffraction source MX2 Beamline, Australian
Synchrotron
Space group P 2 21 21
Unit cell dimensions
a, b, c (Å) 72.01, 115.32, 174.16
, ,  (°) 90, 90, 90
Resolution range (Å) 40.73–2.74 (2.97–2.74)
Ellipsoidal resolution (Å) (direction)a,b 2.723 (a*)
2.768 (b*)
4.111 (c*)
Total no. of reflections (ellipsoidal)a 298,683 (16,041)
No. of unique reflections (ellipsoidal)a 24,308 (1215)
Average multiplicitya 12.3 (13.2)
Completeness (%) (ellipsoidal)a 92.9 (61.7)
























PDB accession code 5W9A
a These statistics are for data that were truncated by STARANISO to remove
poorly measured reflections affected by anisotropy.
b The resolution limits are shown for each of the three reciprocal lattice axes (a*,
b*, and c*). STARANISO has applied an approximately eliptical cutoff to the
reflection data.
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At the interface, the bound section of the long Trim5 helix
occupies the same groove on the LC3B surface that is used by a
typical LIR interaction. Moreover, it is presented in same ori-
entation running parallel with strand 2 of from LC3B (Fig. 2B).
The Trim5–LC3B interface buries 825 Å2 of surface area of
each molecule, corresponding to 5% of the RhT5 88 –295
EK/RD surface area and 11% of the LC3B surface area. An elec-
trostatic surface calculation (Fig. S2) shows an area of strong
negative charge located in the center of the Trim5 coiled coil
that is complementary to the general positive charge of the
LC3B surface. Residues involved in the interaction span the
residue range of Gln189–Glu210 in Trim5.
As seen for a typical LIR motif, the interaction centers
around Trim5 side-chain interactions in the large hydropho-
bic pocket of LC3B. Here, it is the side chain of Trim5 Trp196
that protrudes away from the coiled coil and occupies the large
hydrophobic pocket of LC3B. By contrast, the second hydro-
phobic pocket that is typically occupied by a small hydrophobic
residue is unoccupied in our structure. Instead, the side chain of
Gln203 is located above the pocket with the side chain amide
making a hydrogen bond with the backbone carboxyl of Leu53
in strand 2 of LC3B.
In addition, there are further interactions outside the hydro-
phobic pockets that are mediated by acidic residues on the
Trim5 coiled-coil. Glu192 forms a salt bridge with Lys51 on
strand 2 of LC3B, Glu197 forms a hydrogen bond with His27 at
the C terminus of helix 2 from LC3B, and Glu206 forms poten-
tial salt bridges with Arg69 and Arg70 at the C terminus of helix
3 (Fig. 3). Further interactions are mediated by Ser199 that
makes a hydrogen bond with the backbone carboxyl of Lys51
and the side-chain amine of Gln189 that makes a hydrogen bond
with the side chain of Asp19 on helix 2 of LC3B.
Mutational analysis of the Trim5–LC3B interface
To investigate the importance of specific residues in the
Trim5–LC3B interface, we undertook site-directed mutagen-
esis to probe the contribution of key residues in the interface
and assessed complex formation by SV–AUC. In all assays
LC3B and mutants of RhT5 88 –296 EK/RD were mixed at an
equal concentration of 20 M. The effects of mutations were
judged based upon the magnitude of the perturbation to the fast
moving peak corresponding to the Trim–LC3B complex in the
c(s) analysis. Control size-exclusion chromatography coupled
to multiangle laser light scattering (SEC–MALLS) and c(s) anal-
ysis of all Trim5 mutants alone demonstrate that they retain
the dimeric assembly and do not show large perturbations of
the overall structure of the protein (Fig. S3 and Fig. 4, B and C,
black lines).
The Trp196 side chain is at the center of the interface filling
the large hydrophobic pocket of LC3B. The effect of mutating
this residue to alanine was assessed for binding to each of the six
mATG8 isoforms. Analysis by the c(s) distribution showed that
mutation of Trp196 to alanine abolished binding between the
LC3A, LC3B, LC3C, and GABARAPL2, whereas GABARAP
and GABARAPL1 still bound but with a reduced affinity (Fig.
4A). This suggests that although Trp196 was important for the
affinity of binding, other residues in the interface are able to
maintain the interaction in its absence. To test this hypothesis
we probed the role of other Trim5 residues in the interface by
mutating them to either an alanine or lysine. Each mutant was
assayed against LC3B and GABARAPL1 because these two
mATG8s showed the greatest affinity for WT Trim5.
We first tested residues likely to contribute to the acidic sur-
face charge at the center of the Trim5 coiled coil. Mutations of
both Glu192 and Glu206, that make charge-charge interactions
in the interface, to either alanine or lysine disrupt binding to
LC3B with the lysine mutation showing the anticipated stron-
ger effect (Fig. 4, B and C). In GABARAPL1 the alanine muta-
tions have little effect, whereas the E192K lysine disrupts bind-
ing the E206K mutation has minimal effect. Mutation of Glu197
to alanine, removing the interaction with Gln26/His27, reduced
the binding of LC3B but did not abolish it completely. However,
the mutation had no effect on the binding of GABARAPL1. A
charge swapping mutation of E198K creating repulsion against
Lys51 reduced binding against LC3B and GABARAPL1. These
mutations demonstrate that the general electrostatic interac-
tion contributes to binding.
In addition to the ionic interactions, three hydrogen bond
contacts that contribute to the interface were also identified.
Therefore, these interactions were also probed by mutating the
residue on Trim5 to alanine. Mutation of Gln189, which forms
a hydrogen bond to Asp19 in LC3B, had a minimal effect on
LC3B binding. However, this mutation resulted in an increase
Figure 2. The coiled coil of Trim5 binds LC3B through a helical motif. A,
cartoon representation of the RhT5 88 –296 EK/RD–LC3B protein complex.
Chain A/B (blue/orange) form the Trim5 antiparallel coiled coil dimer, LC3B
molecules are red, and zinc atoms are shown as spheres (silver). B, expanded
view of the LC3B-binding site (left) and comparison with a typical -strand LIR
motif (LC3B–ATG13-LIR PDB code 3WAO). Both the helical and -strand LIR
occupy and proceed in the same orientation through the LC3B-binding site.
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in the S value of the fast moving peak for GABARAPL1 binding,
suggesting a stronger interaction. Structure comparison of
GABARAPL1 with LC3B shows a glutamate at position 19
(compared with the aspartate in LC3B), which would likely
clash with Gln189. Therefore, the observed increase in
GABARAPL1 binding may result from the alanine substitution
relieving this clash.
In a similar manner, mutation of Gln203 to alanine was found
to increase the affinity of binding to LC3B but did not affect
binding to GABARAPL1. Gln203 is located at the edge of the
small hydrophobic pocket and forms a hydrogen bond with
the backbone of Leu53. Mutation to alanine would remove
this hydrogen bond and was predicted to weaken and not
strengthen the interaction. However, it may be that the loss of a
hydrogen bond is compensated for by accommodation of the
alanine residue in the previously unoccupied L pocket on
LC3B.
In addition to interface residues in the Trim5 coiled coil, we
identified three residues on LC3B that were probed by
mutagenesis for their contribution to the binding of Trim5.
Mutation of LC3B His27 to alanine removes a hydrogen bond
formed with Glu197 on Trim5 and has the similar effect to the
RhT5 E197A mutant (Fig. 4D). Substitution of LC3B Arg69 with
either alanine or aspartate is predicted to disrupt ionic interac-
tions with Glu210 and Glu206 of Trim5 and abolished binding.
In the large hydrophobic pocket, Ile23 is packed adjacent to
Trp196 of Trim5. Mutation to an arginine was predicted to
occlude binding into this pocket by filling the same space as
occupied by the tryptophan side chain. Surprisingly, this muta-
tion resulted in a faster moving peak in the SV–AUC analysis,
suggesting a stronger interaction. However, given the guani-
dinium head group of arginine residues can pack in a -
stacking conformation with aromatic side chains, this mode
of interaction with Trp196 provides a possible explanation
for the observed increase in binding.
Previous studies have demonstrated an interaction between
Trim5 and components of the autophagy machinery, includ-
ing members of the ATG family. Furthermore microscopy
experiments have demonstrated co-localization of Trim5 in
autophagic structures in cells (31). The role of autophagy in
restriction is less clear with conflicting results reported (9, 12,
31). To assess whether the interaction with the mATG8s play a
key role in the restriction of retroviral infection, we undertook
restriction assays to examine the effect of W196A and E197A
mutations on restriction by either Trim5 or TrimCyp. The
inclusion of either mutation individually or the double mutant
had no effect on the infectivity of HIV-1 in our restriction assay
(Table 2). Both Trim5 and TrimCyp exhibit a secondary block
to infection in the presence of the proteasome inhibitor
Figure 3. Interactions mediating binding of LC3B to the Trim5 coiled coil. A fold out of the LC3B–RhT5 interaction with RhT5 in blue and LC3B in red
is shown. Residues from the opposing molecule are shown as ball-and-stick representation with potential hydrogen bonds as dashed lines. Trp196 of Trim5
occupies pocket 1 of LC3B.
Figure 4. Mutational analysis of the LC3B-RhT5 interface. A, c(s) analysis
of the RhT5 88 –296 EK/RD-mATG8 interaction with all mATG8 proteins at 20
M equimolar concentration, WT (solid lines), and W196A RhT5 88 –296 EK/RD
(dashed lines). B and C, c(s) analysis of mixtures of WT and mutant RhT5
88 –296 EK/RD with either LC3B (B) or GABARAPL1 (C). Dashed lines indicate
the position of RhT5 88 –296 EK/RD (black) or with the addition of either LC3B
(red) or GABARAPL1 (green). D, c(s) analysis of LC3B mutants (red) mixed with
WT RhT5 88 –296 EK/RD (black).
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MG132. This block occurs after the completion of reverse tran-
scription but prior to integration of the provirus. The inclusion
of proteasome inhibitor at either 1 or 16 g/ml had no effect on
the infectivity of virus in our assay. These results are in agree-
ment with those published by Imam et al. (31). This suggests
that although Trim5 is able to bind LC3B and members of the
mammalian ATG8 family, they do not contribute to the restric-
tion of retroviral infection at either the primary block prior to
reverse transcription or the secondary block after reverse
transcription.
Discussion
During autophagy members of the mATG8 family play a cru-
cial role in phagophore formation and expansion. Modification
of LC3B, and other mATG8s, via cleavage of the C terminus and
the subsequent conjugation of a phosphatidylethanolamine
lipid to the C terminus, is a key marker of autophagosome for-
mation. This modification anchors the mATG8s to the
autophagosome where they act as an adaptor, tethering sub-
strate proteins, including components of the autophagosome
maturation pathway and selective autophagy receptors, to the
autophagosomal membrane.
Previously characterized interactions between ATG8 pro-
teins and their binding partners show a conserved mode of
interaction (3) comprising a linear binding motif with the con-
sensus sequence of [DEST][WFY]-{RGKP}{RGKP}-[ILV]
arranged as a -strand with the large and small hydrophobic
residues located in pockets on the surface of the ATG8 protein.
The structure now presented here demonstrates a second mode
of binding where a helical motif occupies the same binding
groove on the surface of LC3B with the large hydrophobic
pocket similarly occupied.
Based upon our structural observations and biophysical
characterization of this interaction we propose a “helical LIR”
motif, where upon accounting for the difference in residue
spacing imposed by the helical secondary structure an equiva-
lent consensus sequence is accommodated. This new motif
would have a consensus sequence of an acidic residue with a
three-amino acid spacer N-terminal to the large aromatic
amino acid and then a further six amino acids N-terminal to the
residue that occupies the small hydrophobic pocket ([DEST]-
X3-[WFY]-X6-[LIVQ]). This results in key residues being pre-
sented along a single face of an -helix. In the case of Trim5
the residues Glu192, Trp196, and Gln203 fulfill these positions,
with Gln203 located on the edge of the small hydrophobic
pocket. Mutation of these residues alters binding, either
decreasing the affinity or in the case of Gln203 substitution with
a small hydrophobic residues results in an increase in binding.
Although these residues are located in key positions in the
binding groove, our data demonstrate that other residues pres-
ent on the helix contribute to binding. This is consistent with
the increased surface area and number of residues presented by
the helix, 10 residues burying 820 Å2 compared with 5 amino
acids burying 610 Å2 for a typical LIR motif. Furthermore,
mutation of residues in the helical LIR contribute differently to
binding of LC3B and GABARAPL1, suggesting subtle differ-
ences in the recognition of different ATG8 proteins.
To examine further features that contribute to the LC3B-
binding site, we aligned the coiled-coil region of Trim5 from
57 species with unique sequences present in the UniProt data-
base (Fig. S4). It is evident that although there are conserved
residues that we have shown contributing to binding, other
amino acids are less well-conserved. Of note, Trp196 is not
strictly conserved across the Trim5 of all species. Mapping
sequences to an evolutionary tree, we observe a clear sequence
division at this position between the new- and old-world mon-
keys. This divergence maps to after the separation between the
new- and old-world monkeys that occurred during the Oligo-
cene era, between 30 and 40 million years ago and prior to the
divergence of the apes and old-world monkeys 10 –20 million
years ago (32), suggesting that a tryptophan at this position has
been acquired and retained.
Based upon previously determined structures of the Trim5
PRY/SPRY domain (33, 34) and an overlap with residues in the
L2 linker region that are present in structures of both the PRY/
SPRY domain (34) and the Bbox coiled-coil region of Trim5
(16), it is possible to construct a model of the Trim5 molecule
that positions the SPRY domain from each monomer adjacent
to one another at the center of the coiled-coil region (16,
35–37). This model positions the variable loops of the SPRY
domain to recognize the retroviral capsid, and the Bbox and
RING domains are available for higher-order assembly and
ubiquitylation. Inclusion of LC3B into this model using our
current structure (Fig. 5) now positions the LC3B either side of
the center of the coiled-coil, adjacent to the SPRY domains,
without interfering with the positioning of the SPRY domains
or making interactions with regions of the L2. Further exami-
nation of the orientation of the LC3B relative to the SPRY
domain positions the C termini of the LC3Bs on the opposite
side of the coiled coil. This demonstrates that LC3B could be
accommodated within the Trim5 higher-order assembly and
would allow the SPRY domain to remain accessible to recognize
substrates, whereas lipidated LC3B could tether Trim5 to the
autophagosomal membrane.
Comparison of the affinity of interaction of the helical LIR
with that of the typical LIR–LC3B interactions suggests that the
LC3B-Trim5 interaction is at the lower end of reported affin-
ities, with typical interaction in the KD range of 1–50 M range
(38). However, because both LC3B molecules present in our
model are oriented with the C terminus exposed, we would
expect a single Trim5 dimer to bind two LC3B molecules.
With LC3B tethered on the autophagosomal membrane, this
Table 2
Restriction assay of Trim5 and TrimCyp mutants in the presence and
absence of proteasome inhibitor MG132
The cells were transduced with vectors expressing YFP and either TRIM5,
TRIMCyp, or their mutants before challenging with HIV-1 expressing GFP, in the
presence or absence of MG132. The cells were analyzed by flow cytometry 48 h after
challenge. The numbers are ratios of percentages of infected cells containing restriction







Trim 5 0.12  0.06 0.14  0.04 0.12  0.01
Trim 5 W196A/E197A 0.10  0.05 0.11  0.05 0.09  0.03
Trim 5 E197A 0.12  0.03 0.12  0.04 0.19  0.03
TrimCypA 0.10  0.06 0.10  0.02 0.09  0.02
TrimCypA W196A 0.08  0.03 0.08  0.05 0.05  0.03
TrimCypA W196A/E197A 0.10  0.06 0.11  0.07 0.05  0.01
TrimCypA E197A 0.12  0.05 0.13  0.08 0.11  0.03
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would generate an avid interaction and greatly amplify the
strength of binding.
Members of the TRIM protein family have an emerging
role in autophagy. The structure presented here provides the
first molecular insight into the interaction of TRIM proteins
with components of the autophagy machinery. This interac-
tion proceeds through a helical motif and alters the current




Mammalian ATG8 and Trim5 constructs were inserted
into pET47 and expressed with an N-terminal His tag in E. coli
LOBSTR BL21(DE3) cells. The proteins were purified by
immobilized nickel-affinity chromatography, and the His tag
was removed by incubation with HRV 3C protease prior to
anion exchange (6 ml of Resource Q) and size-exclusion chro-
matography using an Superdex 200 (16/60) column equili-
brated with 10 mM Tris/HCl, pH 7.8, 150 mM NaCl, 0.1 mM
TCEP. Proteins were concentrated to 20 mg/ml using Vivaspin
concentrators and stored at 80 °C until required.
Analytical ultracentrifugation
All sedimentation velocity analytical ultracentrifugation
experiments were carried out at 20 °C (293 K) using a Beck-
man Coulter model XL-I with absorbance optics in double
sector charcoal filled Epon center pieces. All samples were
centrifuged in a Beckman Coulter eight-hole An-50 Ti rotor
at 50,000 rpm. Prior to the experiments all samples were
exhaustively dialyzed against a buffer containing 10 mM
Tris/HCl, pH 8, 150 mM NaCl, and 0.1 mM TCEP. SEDN-
TERP (39) was used to determine a solvent density of 1.005 g
ml1 and a viscosity of 0.01021 cp. The data were analyzed
using a continuous c(s) distribution in SEDFIT (39). Because
many experiments contained mixtures of two proteins, each
with a unique partial specific volume, a constant value of
0.73 ml g1 was used for all samples.
Crystallization and structure determination
The Trim5 construct RhT5 88 –296 E120K/R121D and
LC3B construct 2–119 were mixed at equimolar concentra-
tions (330 M) and crystallized by the vapor diffusion method at
290 K. The protein mixture was combined with a precipitant-
mixture containing 0.2 M NH4Cl, 0.1 M Tris/HCl, pH 8, 20%
PEG 6,000 at a ratio of 1:1 and allowed to equilibrate. Large
plate crystals formed over a period of 48 h.
The crystals were harvested into a cryoprotectant containing
the precipitant mixture supplemented with 20% glycerol and
flash-frozen in liquid nitrogen. Diffraction experiments were
conducted at the Australian synchrotron. The data were col-
lected at 9900 eV.
The data were indexed with XDS (40), and initial merging
and scaling with AIMLESS (41) indicated significant anisotropy
in the strength of diffraction. Thus an anisotropic resolution
cutoff was applied to the data by the STARANISO server
(Global Phasing Limited) giving a maximum resolution of
2.74 Å. The structure was then determined by molecular
replacement in PHASER (42) using the Trim5 dimer (PDB
code 4TN3) and a single LC3B molecule (PDB code 3WAO)
as search models. The second LC3B molecule was generated
by noncrystallographic symmetry, rotating the model 180°
and aligning based on the Trim5 dimer. The model was
then completed using iterative rounds of manual model
building in COOT (43) and refinement in PHENIX (44). The
data collection and refinement statistics are presented in
Table 1.
SEC–MALLS
SEC–MALLS was used to determine the molecular weight
and oligomeric state of RhT5 88 –296 EK/RD and LC3B
mutants. Samples (100 l) were applied to a Superdex 75
Increase 10/300 column in a running buffer containing 10 mM
Tris/HCl, pH 7.8, 150 mM NaCl, 0.1 mM TCEP, and 3 mM azide.
The MALLS unit comprised a Dionex HPLC with a PSS
SLD7000 7-angle MALLS detector and a Shodex RI-101 differ-
ential refractive index detector. The data were analyzed using
the PSS winGPC Unichrom software package.
Restriction assays
CRFK cells were transduced with vectors expressing YFP
and either TRIM5, TRIMCyp, or their mutants before chal-
lenging with HIV-1 expressing GFP, in the presence or
absence of either 1 g/ml MG132 or 16 g/ml MG132. The
cells were analyzed by flow cytometry 48 h after challenge.
The numbers are ratios of percentages of infected cells con-
taining restriction factor to percentages of infected cells that
do not contain restriction factor. A ratio of less than 0.3 was
taken to indicate restriction (45).
Figure 5. Model of Trim5–LC3B complex. The SPRY domains from Rhe-
sus Trim5 (PDB code 4B3N) are positioned on the Trim5 Bbox coiled coil
(PDB code 4TN3) by superposition of common residues. The structure of
the RhT5–LC3B complex (this work) was then superimposed on 4TN3 to
position the LC3B molecules. This model positions the variable loops of
the SPRY domain to recognize capsid, whereas the lipidation site at the C
terminus of LC3B is available to be incorporated in the autophagosomal
membrane.
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